DOCU.NASDAQDocusign, INC

Form 4: DocuSign Director Granted 6,265 Restricted Stock Units

Sentiment:

Insider Transaction Report


DocuSign Director Michael George Rosenbaum was granted 6,265 Restricted Stock Units, vesting quarterly over three years starting September 3, 2025.

Summary

  • Michael George Rosenbaum, a Director at DocuSign, Inc. (DOCU), was granted 6,265 Restricted Stock Units (RSUs).
  • Each RSU represents a contingent right to receive one share of DocuSign's common stock.
  • The RSUs will vest in twelve equal quarterly installments over three years.
  • The vesting commencement date for these RSUs is September 3, 2025.
  • Vesting is contingent upon Mr. Rosenbaum remaining a service provider through each vesting date.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a director is a positive signal for aligning long-term interests and retaining key talent, although it's a routine compensation event rather than a significant strategic announcement.

Positives

  • The grant of 6,265 Restricted Stock Units to a Director aligns management incentives with long-term shareholder value.
  • The three-year vesting schedule encourages sustained commitment and performance from the Director.

Risks

  • Vesting of the Restricted Stock Units is contingent upon Michael George Rosenbaum remaining a service provider through each vesting date, meaning the shares are not guaranteed if his service terminates.

Future Outlook

The Restricted Stock Units will vest in twelve equal quarterly installments over three years, commencing September 3, 2025, subject to continued service, indicating a future commitment and incentive structure for the director.

Industry Context

Equity grants like Restricted Stock Units are a standard component of executive and director compensation packages across the technology industry, aiming to align long-term interests with shareholders and retain key talent.

Comparison to Industry Standards

  • The grant of Restricted Stock Units (RSUs) to directors is a common practice in the technology sector, similar to companies like Adobe (ADBE) or Salesforce (CRM), which use equity compensation to incentivize long-term performance and retention.
  • A three-year quarterly vesting schedule is typical for such grants, providing a sustained incentive for the director's continued service and contribution to company growth, comparable to vesting schedules seen at peer companies.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director CompensationGrant of 6,265 Restricted Stock Units to Director Michael George Rosenbaum as part of his compensation package.09/09/2025Aligns director's long-term interests with shareholder value and serves as a retention incentive.

Stakeholder Impact

  • Shareholders: Potential for increased alignment of director's interests with long-term shareholder value through equity ownership.
  • Employees: No direct impact on general employees, but reflects standard compensation practices for leadership.

Next Steps

  • The Restricted Stock Units will begin vesting on September 3, 2025, in twelve equal quarterly installments over three years.

Key Dates

DateDescription
09/03/2025Vesting commencement date for the Restricted Stock Units.
09/09/2025Date of earliest transaction, when 6,265 Restricted Stock Units were acquired.
09/10/2025Date the Form 4 was signed by the attorney-in-fact.

Recommendation

hold

This Form 4 reports a routine equity grant to a director as part of their compensation. While it aligns the director's interests with long-term shareholder value, it does not present new information that would significantly alter the fundamental investment outlook for DocuSign, warranting a 'hold' recommendation based solely on this filing.

Keywords

DocuSign, DOCU, Restricted Stock Units, RSU, Insider Transaction, Form 4, Director Compensation, Equity Grant, Michael George Rosenbaum

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.